New Study Presents Impressive Results of Nexstim SmartFocus® nTMS Language Mapping

Press release, Helsinki, 13 January 2021 at 13.00 (EET)New Study Presents Impressive Results of Nexstim SmartFocusA® nTMS Language MappingNexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company") announces that a new study published in Cancers in January presents impressive results of nTMS language mapping in a large amount of patients. Using the robustness of Nexstim SmartFocusA® nTMS data, the authors also introduce a new and more precise classification of what it means to be a a??language eloquenta?? tumour, challenging the traditional methods that seek to only identify hemispheric dominance for language.The study a??Non-Invasive Mapping for Effective Preoperative Guidance to Approach Highly Language-Eloquent Gliomasa??A Large Scale Comparative Cohort Study Using a New Classification for Language Eloquencea??, using Nexstima??s NBS System with SmartFocusA® nTMS, was published by a neurosurgical team at Technical University of Munich (TUM) in Germany.The study included 140 consecutive patients with suspected language-eloquent brain tumours. Nexstim SmartFocusA® nTMS pre-operative language mapping was performed on all these patients. In a very high number of patients tumour could be removed to the maximum extent, with gross total resection (GTR) achieved in 82.3% of cases.
See also:
Leave a comment
  • Latest
  • Read
  • Commented
Calendar Content
«    Февраль 2021    »